Yang Q - Search Results

1

Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.

Yang Q, Wu K, Ji M, Jin W, He N, Shi B, Hou P. Yang Q, et al. J Biomed Nanotechnol. 2013 Sep;9(9):1607-16. doi: 10.1166/jbn.2013.1713. J Biomed Nanotechnol. 2013. PMID: 23980508

2

Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.

Zhang G, Qu Y, Dang S, Yang Q, Shi B, Hou P. Zhang G, et al. Among authors: yang q. Diagn Pathol. 2013 Oct 21;8:173. doi: 10.1186/1746-1596-8-173. Diagn Pathol. 2013. PMID: 24144008 Free PMC article.

3

A Strategy for Accurate Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine at CpG Sites Within Gene Promoter.

Qui Y, Yang Q, Sui F, Lu R, Dang S, Ji M, He N, Shi B, Hou P. Qui Y, et al. Among authors: yang q. J Biomed Nanotechnol. 2015 Jun;11(6):1016-26. doi: 10.1166/jbn.2015.2092. J Biomed Nanotechnol. 2015. PMID: 26353591

4

Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma.

Zhang Y, Wu K, Shao Y, Sui F, Yang Q, Shi B, Hou P, Ji M. Zhang Y, et al. Among authors: yang q. Am J Cancer Res. 2016 May 1;6(5):1089-98. eCollection 2016. Am J Cancer Res. 2016. PMID: 27294001 Free PMC article.

5

Long telomere length predicts poor clinical outcome in esophageal cancer patients.

Lv Y, Zhang Y, Li X, Ren X, Wang M, Tian S, Hou P, Shi B, Yang Q. Lv Y, et al. Among authors: yang q. Pathol Res Pract. 2017 Feb;213(2):113-118. doi: 10.1016/j.prp.2016.11.010. Epub 2016 Nov 16. Pathol Res Pract. 2017. PMID: 28027815

6

ACYP2 contributes to malignant progression of glioma through promoting Ca²⁺ efflux and subsequently activating c-Myc and STAT3 signals.

Li M, Ruan B, Wei J, Yang Q, Chen M, Ji M, Hou P. Li M, et al. Among authors: yang q. J Exp Clin Cancer Res. 2020 Jun 9;39(1):106. doi: 10.1186/s13046-020-01607-w. J Exp Clin Cancer Res. 2020. PMID: 32517717 Free PMC article.

7

Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers.

Qu Y, Shi L, Wang D, Zhang B, Yang Q, Ji M, Shi B, Hou P. Qu Y, et al. Among authors: yang q. Int J Cancer. 2014 Jun 15;134(12):2993-4. doi: 10.1002/ijc.28633. Epub 2013 Dec 5. Int J Cancer. 2014. PMID: 24285288 No abstract available.

8

TERT promoter mutations predict worse survival in laryngeal cancer patients.

Qu Y, Dang S, Wu K, Shao Y, Yang Q, Ji M, Shi B, Hou P. Qu Y, et al. Among authors: yang q. Int J Cancer. 2014 Aug 15;135(4):1008-10. doi: 10.1002/ijc.28728. Epub 2014 Jan 27. Int J Cancer. 2014. PMID: 24436132 No abstract available.

9

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients.

Dang S, Qu Y, Wei J, Shao Y, Yang Q, Ji M, Shi B, Hou P. Dang S, et al. Among authors: yang q. Diagn Pathol. 2014 Feb 5;9:28. doi: 10.1186/1746-1596-9-28. Diagn Pathol. 2014. PMID: 24499477 Free PMC article.

10

PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.

Cui B, Yang Q, Guan H, Shi B, Hou P, Ji M. Cui B, et al. Among authors: yang q. J Clin Endocrinol Metab. 2014 Jun;99(6):E962-70. doi: 10.1210/jc.2013-3147. Epub 2014 Feb 10. J Clin Endocrinol Metab. 2014. PMID: 24512488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,450 results

Search Page

Filters